✦ LIBER ✦

Pancreatitis in patients with lipoprotein lipase deficiency and the effect of alipogene tiparvovec (AAV1-LPLS447X gene therapy)

✍ Scribed by Deakin, M.; De Wal, J.; Camozzi, C.; Bruno, M.; Ruszniewski, P.; Gaudet, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and long-term safety of alipoge

✍ Gaudet, D; Méthot, J; Déry, S; Brisson, D; Essiembre, C; Tremblay, G; Tremblay, 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 613 KB

Gene therapy with alipogene tiparvovec b

✍ S. Greentree; D. Gaudet; E. Stroes; N. van den Bulk; J. de Wal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

557 Alipogene Tiparvovec Gene Therapy Re

✍ Marco J. Bruno; Mark Deakin; Philippe B. Ruszniewski; Nick V. Bulk; Janneke de W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 179 KB

35 ALIPOGENE TIPARVOVEC GENE THERAPY SIG

✍ Greentree, S.; Méthot, J.; Déry, S.; Tremblay, K.; de Wal, J.; van den Bulk, N.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Abstract: 554 AN OPEN-LABEL, DOSE ESCALA

✍ Gaudet, D; Brisson, D; Methot, J; van Deventer, S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB

L7 RESULTS OF FIRST FOLLOW UP STUDY WITH

✍ Gaudet, D.; de Wal, J.; Brisson, D.; van den Bulk, N.; Greentree, S.; Méthot, J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB